CRMD Q4 2025 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$536M

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$129M+312.1% YoY

Gross Profit

$107M83.4% margin

Operating Income

$59M46.0% margin

Net Income

$14M10.9% margin

EPS (Diluted)

$0.16

QoQ Revenue Growth

+23.3%

Cash Flow

Operating Cash Flow

$94M

Free Cash Flow

$94M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$826M

Total Liabilities

$421M

Stockholders' Equity

$405M

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$31M	+312.1%
Gross Profit	$107M	$30M	+257.3%
Operating Income	$59M	$13M	+357.1%
Net Income	$14M	$13M	+4.1%

Revenue Segments

Product

$203M100%